List of Tables
Table 1. Oral Anti-diabetes Drugs Market Trends
Table 2. Oral Anti-diabetes Drugs Market Drivers & Opportunity
Table 3. Oral Anti-diabetes Drugs Market Challenges
Table 4. Oral Anti-diabetes Drugs Market Restraints
Table 5. Global Oral Anti-diabetes Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oral Anti-diabetes Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Oral Anti-diabetes Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Oral Anti-diabetes Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Oral Anti-diabetes Drugs
Table 10. Global Oral Anti-diabetes Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-diabetes Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Oral Anti-diabetes Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Oral Anti-diabetes Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Oral Anti-diabetes Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Oral Anti-diabetes Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Oral Anti-diabetes Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Oral Anti-diabetes Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Oral Anti-diabetes Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Oral Anti-diabetes Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Oral Anti-diabetes Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Oral Anti-diabetes Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Oral Anti-diabetes Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Oral Anti-diabetes Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Oral Anti-diabetes Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Oral Anti-diabetes Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Oral Anti-diabetes Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Oral Anti-diabetes Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Oral Anti-diabetes Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Oral Anti-diabetes Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Sanofi Basic Information List
Table 32. Sanofi Description and Business Overview
Table 33. Sanofi Oral Anti-diabetes Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Sanofi (2019-2024)
Table 35. Sanofi Recent Developments
Table 36. Eli Lilly Basic Information List
Table 37. Eli Lilly Description and Business Overview
Table 38. Eli Lilly Oral Anti-diabetes Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Eli Lilly (2019-2024)
Table 40. Eli Lilly Recent Developments
Table 41. AstraZeneca plc Basic Information List
Table 42. AstraZeneca plc Description and Business Overview
Table 43. AstraZeneca plc Oral Anti-diabetes Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of AstraZeneca plc (2019-2024)
Table 45. AstraZeneca plc Recent Developments
Table 46. Astellas Pharma Inc Basic Information List
Table 47. Astellas Pharma Inc Description and Business Overview
Table 48. Astellas Pharma Inc Oral Anti-diabetes Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Astellas Pharma Inc (2019-2024)
Table 50. Astellas Pharma Inc Recent Developments
Table 51. Johnson & Johnson (Janssen Pharmaceuticals) Basic Information List
Table 52. Johnson & Johnson (Janssen Pharmaceuticals) Description and Business Overview
Table 53. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Johnson & Johnson (Janssen Pharmaceuticals) (2019-2024)
Table 55. Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments
Table 56. Boehringer Ingelheim Basic Information List
Table 57. Boehringer Ingelheim Description and Business Overview
Table 58. Boehringer Ingelheim Oral Anti-diabetes Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Boehringer Ingelheim (2019-2024)
Table 60. Boehringer Ingelheim Recent Developments
Table 61. Merck Basic Information List
Table 62. Merck Description and Business Overview
Table 63. Merck Oral Anti-diabetes Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Merck (2019-2024)
Table 65. Merck Recent Developments
Table 66. Takeda Basic Information List
Table 67. Takeda Description and Business Overview
Table 68. Takeda Oral Anti-diabetes Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Takeda (2019-2024)
Table 70. Takeda Recent Developments
Table 71. Bristol Myers Squibb Basic Information List
Table 72. Bristol Myers Squibb Description and Business Overview
Table 73. Bristol Myers Squibb Oral Anti-diabetes Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Bristol Myers Squibb (2019-2024)
Table 75. Bristol Myers Squibb Recent Developments
Table 76. Novartis Basic Information List
Table 77. Novartis Description and Business Overview
Table 78. Novartis Oral Anti-diabetes Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Novartis (2019-2024)
Table 80. Novartis Recent Developments
Table 81. Pfizer Basic Information List
Table 82. Pfizer Description and Business Overview
Table 83. Pfizer Oral Anti-diabetes Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Pfizer (2019-2024)
Table 85. Pfizer Recent Developments
Table 86. Abbott Basic Information List
Table 87. Abbott Description and Business Overview
Table 88. Abbott Oral Anti-diabetes Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Abbott (2019-2024)
Table 90. Abbott Recent Developments
Table 91. Biocon Basic Information List
Table 92. Biocon Description and Business Overview
Table 93. Biocon Oral Anti-diabetes Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Biocon (2019-2024)
Table 95. Biocon Recent Developments
Table 96. Sunpharma Basic Information List
Table 97. Sunpharma Description and Business Overview
Table 98. Sunpharma Oral Anti-diabetes Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Sunpharma (2019-2024)
Table 100. Sunpharma Recent Developments
Table 101. Novo Nordisk Basic Information List
Table 102. Novo Nordisk Description and Business Overview
Table 103. Novo Nordisk Oral Anti-diabetes Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Novo Nordisk (2019-2024)
Table 105. Novo Nordisk Recent Developments
Table 106. Piramal Healthcare Basic Information List
Table 107. Piramal Healthcare Description and Business Overview
Table 108. Piramal Healthcare Oral Anti-diabetes Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Piramal Healthcare (2019-2024)
Table 110. Piramal Healthcare Recent Developments
Table 111. Bayer Healthcare Basic Information List
Table 112. Bayer Healthcare Description and Business Overview
Table 113. Bayer Healthcare Oral Anti-diabetes Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Bayer Healthcare (2019-2024)
Table 115. Bayer Healthcare Recent Developments
Table 116. Dr. Reddy’s Laboratories Ltd Basic Information List
Table 117. Dr. Reddy’s Laboratories Ltd Description and Business Overview
Table 118. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Dr. Reddy’s Laboratories Ltd (2019-2024)
Table 120. Dr. Reddy’s Laboratories Ltd Recent Developments
Table 121. Glenmark Pharmaceuticals Ltd Basic Information List
Table 122. Glenmark Pharmaceuticals Ltd Description and Business Overview
Table 123. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Oral Anti-diabetes Drugs Business of Glenmark Pharmaceuticals Ltd (2019-2024)
Table 125. Glenmark Pharmaceuticals Ltd Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Oral Anti-diabetes Drugs Downstream Customers
Table 129. Oral Anti-diabetes Drugs Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Oral Anti-diabetes Drugs Product Picture
Figure 2. Global Oral Anti-diabetes Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oral Anti-diabetes Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Oral Anti-diabetes Drugs Report Years Considered
Figure 5. Global Oral Anti-diabetes Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Anti-diabetes Drugs Revenue in 2023
Figure 7. Oral Anti-diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Liquid Picture
Figure 9. Capsule Picture
Figure 10. Tablet Picture
Figure 11. Global Oral Anti-diabetes Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Oral Anti-diabetes Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospital Pharmacies
Figure 14. Product Picture of Retail Pharmacies
Figure 15. Product Picture of Online Pharmacies
Figure 16. Global Oral Anti-diabetes Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Oral Anti-diabetes Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Oral Anti-diabetes Drugs Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Oral Anti-diabetes Drugs Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Oral Anti-diabetes Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Oral Anti-diabetes Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Oral Anti-diabetes Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Oral Anti-diabetes Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Oral Anti-diabetes Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Oral Anti-diabetes Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Oral Anti-diabetes Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Oral Anti-diabetes Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Oral Anti-diabetes Drugs Sales Value (%), (2019-2030)
Figure 29. United States Oral Anti-diabetes Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Oral Anti-diabetes Drugs Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Oral Anti-diabetes Drugs Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Oral Anti-diabetes Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Oral Anti-diabetes Drugs Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Oral Anti-diabetes Drugs Sales Value by Application (%), 2023 VS 2030
Figure 35. China Oral Anti-diabetes Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Oral Anti-diabetes Drugs Sales Value by Type (%), 2023 VS 2030
Figure 37. China Oral Anti-diabetes Drugs Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Oral Anti-diabetes Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Oral Anti-diabetes Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Oral Anti-diabetes Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Oral Anti-diabetes Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Oral Anti-diabetes Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Oral Anti-diabetes Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Oral Anti-diabetes Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Oral Anti-diabetes Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Oral Anti-diabetes Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. India Oral Anti-diabetes Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Oral Anti-diabetes Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. India Oral Anti-diabetes Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. Oral Anti-diabetes Drugs Industrial Chain
Figure 51. Oral Anti-diabetes Drugs Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
